Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. Drilon
    Drilon
  4. Ladanyi
    Ladanyi
  5. Yu
    Yu
  6. Rekhtman
    Rekhtman
  7. Miller
    Miller
  8. Offin
    Offin
  9. Huang
    Huang
  10. Li
    Li

Groups

  1. Department of Medicine (69)
  2. Solid Tumor Oncology Division (69)
  3. Thoracic Oncology (69)
  4. GSK Faculty (22)
  5. Human Oncology and Pathogenesis Program (18)
  6. Tow Center for Developmental Oncology (TCDO) (16)
  7. Epidemiology and Biostatistics (12)
  8. Surgery (12)
  9. Biostatistics Service (11)
  10. Sloan Kettering Institute Postdocs (10)
Search Within
  1. "Gregory Riely"
  2. "Journal of Thoracic Oncology"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (69)
Groups
  1. Department of Medicine (69)
  2. Solid Tumor Oncology Division (69)
  3. Thoracic Oncology (69)
  4. GSK Faculty (22)
  5. Human Oncology and Pathogenesis Program (18)
  6. Tow Center for Developmental Oncology (TCDO) (16)

More Groups

People
  1. Gregory Riely (69)
  2. Mark Kris (25)
  3. Marc Ladanyi (16)
  4. Alexander Drilon (13)
  5. Helena Yu (11)
  6. Natasha Rekhtman (10)

More People

Years
  1. 2023 (5)
  2. 2022 (1)
  3. 2021 (9)
  4. 2020 (1)
  5. 2019 (6)
  6. 2018 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (69)

Results (69)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brain metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Sui, J. S.; Chen, M. F.; Wilcox, J.; Yang, S. R.; Li, B. T.; Riely, G. J.; Offin, M.; Yu, H. A.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • KRYSTAL-1: Two-year follow-up of adagrasib (MRTX849) monotherapy in patients with advanced/metastatic KRASG12C-mutated NSCLC
    Meeting Abstract

    Gadgeel, S.; Jänne, P. A.; Spira, A. I.; Ou, S. H. I.; Heist, R. S.; Pacheco, J. M.; Johnson, M. L.; Sabari, J. K.; Leventakos, K.; Mason, J. A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Adagrasib (MRTX849) in patients with advanced/metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC): Preliminary analysis of mutation allele frequency
    Meeting Abstract

    Jänne, P. A.; Spira, A.; Riely, G. J.; Gadgeel, S.; Heist, R.; Ou, S. H. I.; Johnson, M. L.; Sabari, J.; Velastegui, K.; Christensen, J. G.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • PRO-CTCAE analysis of mobocertinib in EGFR exon 20 insertion‒positive metastatic non‒small cell lung cancer (NSCLC)
    Meeting Abstract

    García Campelo, M. R.; Zhou, C.; Ramalingam, S. S.; Lin, H. M.; Kim, T. M.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Biber, J.; Romero, H.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes and characteristics of unresectable locally advanced thymic malignancies
    Meeting Abstract

    Sideris, A.; Li, X.; Oufkir, H.; Curry, M.; Tan, K. S.; Araujo-Filho, J.; Robinson, E.; Jones, D.; Ginsberg, M.; Rimner, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib in platinum-pretreated EGFR exon 20 insertion+ metastatic NSCLC patients with/without prior anti-PD(L)-1 therapy
    Meeting Abstract

    Janne, P.; Ramalingam, S.; Kim, T.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Jin, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib (TAK-788) in EGFR exon 20 insertion+ metastatic NSCLC: Patient-reported outcomes from EXCLAIM extension cohort
    Meeting Abstract

    García Campelo, M. R.; Zhou, C.; Ramalingam, S.; Lin, H.; Kim, T.; Riely, G.; Mekhail, T.; Nguyen, D.; Goodman, E.; Le, K.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib in EGFR exon 20 insertion-positive metastatic NSCLC patients with disease control on prior EGFR TKI therapy
    Meeting Abstract

    Spira, A.; Ramalingam, S.; Neal, J.; Piotrowska, Z.; Mekhail, T.; Tsao, A.; Gentzler, R.; Riely, G.; Bazhenova, L.; Gadgeel, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save